Targeting the oncofetal Thomsen-Friedenreich disaccharide using Jacalin-PEG phthalocyanine gold nanoparticles for photodynamic cancer therapy

Girgis Obaid, Isabelle Chambrier, Michael J. Cook, David A. Russell

    Research output: Contribution to journalArticlepeer-review

    105 Citations (Scopus)

    Abstract

    Light-sensitive: Targeted photodynamic therapy is achieved by using gold nanoparticles that are stabilized by a mixed monolayer of a hydrophobic zinc phthalocyanine photosensitizer, which produces cytotoxic singlet oxygen, and a water-soluble thiol-functionalized poly(ethylene glycol) carrying the lectin jacalin, which targets the Thomsen–Friedenreich disaccharide antigen at the surface of cancer cells.
    Original languageEnglish
    Pages (from-to)6158-6162
    Number of pages5
    JournalAngewandte Chemie-International Edition
    Volume51
    Issue number25
    DOIs
    Publication statusPublished - 2012

    Cite this